Evidence map›Paper›PMID 22028889›Full record

ArticlePloS one2011

Osteoblast-specific transcription factor Osterix increases vitamin D receptor gene expression in osteoblasts.

Chi Zhang, Wanjin Tang, Yang Li, Fan Yang, Diane R Dowd, Paul N MacDonald

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. Mutanobactin-D, aInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Evaluation of Wound-Healing and Antioxidant Effects ofMolecules (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Vitamin D activation of functionally distinct regulatory miRNAs in primary human osteoblasts.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2013
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Chi ZhangBone Research Laboratory, Texas Scottish Rite Hospital for Children, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America. Chi5.Zhang@utsouthwestern.edu
Wanjin Tang
Yang Li
Fan Yang
Diane R Dowd
Paul N MacDonald
Case Western Reserve University · USSouthwestern Medical Center · USThe University of Texas Southwestern Medical Center · US

Funding

VIT D AND ESTROGEN RECEPTOR COACTIVATORS IN OSTEOBLASTSR01DK053980 · NIDDK · SAINT LOUIS UNIVERSITY · PI MACDONALD, PAUL N · 1998 to 2010
$2.7M
NIDDK NIH HHS R01 DK053980NIDDK NIH HHS R01-DK53980
6 · The paper itself

Abstract

Osterix (Osx) is an osteoblast-specific transcription factor required for osteoblast differentiation from mesenchymal stem cells. In Osx knock-out mice, no bone formation occurs. The vitamin D receptor (VDR) is a member of the nuclear hormone receptor superfamily that regulates target gene transcription to ensure appropriate control of calcium homeostasis and bone development. Here, we provide several lines of evidence that show that the VDR gene is a target for transcriptional regulation by Osx in osteoblasts. For example, calvaria obtained from Osx-null embryos displayed dramatic reductions in VDR expression compared to wild-type calvaria. Stable overexpression of Osx stimulated VDR expression in C2C12 mesenchymal cells. Inhibition of Osx expression by siRNA led to downregulation of VDR. In contrast, Osx levels remained unchanged in osteoblasts in VDR-null mice. Mechanistic approaches using transient transfection assays showed that Osx directly activated a 1 kb fragment of the VDR promoter in a dose-dependent manner. To define the region of the VDR promoter that was responsive to Osx, a series of VDR promoter deletion mutants were examined and the minimal Osx-responsive region was refined to the proximal 120 bp of the VDR promoter. Additional point mutants were used to identify two GC-rich regions that were responsible for VDR promoter activation by Osx. Chromatin immunoprecipitation assays demonstrated that endogenous Osx was associated with the native VDR promoter in primary osteoblasts in vivo. Cumulatively, these data strongly support a direct regulatory role for Osx in VDR gene expression. They further provide new insight into potential mechanisms and pathways that Osx controls in osteoblasts and during the process of osteoblastic cell differentiation.

Indexed as

Gene Expression RegulationAnimalsCell DifferentiationCell LineGC Rich SequenceMiceMice, Inbred C57BLOsteoblastsPolymerase Chain ReactionPromoter Regions, GeneticReceptors, CalcitriolRNA, Small InterferingSp7 Transcription FactorTranscription FactorsReceptors, CalcitriolRNA, Small InterferingSp7 protein, mouseSp7 Transcription FactorTranscription Factors

Identifiers

PMID22028889
PMCPMC3196580
OpenAlexW1976535297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.